Though Investment In TB R&D Increased In 2016, Funding Represents One-Third Of Need, Report Says

Center for Global Health Policy’s “Science Speaks”: TB R&D spending climbs — but not enough
Antigone Barton, senior editor and writer of “Science Speaks,” discusses a Treatment Action Group report that found “[i]nvestment in research and development toward new tuberculosis drugs, diagnostic tests, and preventive measures increased in 2016 for the first time in seven years … [T]he report shows spending from national governments and multilateral organizations drove the increase.” However, the authors of the report note the spending represents only one-third of what advocates say is needed in the TB response (11/8).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.